Andersen Sterilizers & Andersen Scientific First Awardee in FDA’s 510(k) Ethylene Oxide Sterility Change Master File Pilot Program
|

Andersen Sterilizers & Andersen Scientific First Awardee in FDA’s 510(k) Ethylene Oxide Sterility Change Master File Pilot Program

ByAngela Labrecque

HAW RIVER, N.C. – Andersen Sterilizers and its sister company, contract sterilization specialist Andersen Scientific, were awarded the very first master file in the FDA’s 510(k) Ethylene Oxide (EO) Sterility Change Master File Pilot Program. “This master file award from the FDA makes it official, switching to Andersen from a traditional sterilization method just got…

Bridging the COVID Gap (Year)
| |

Bridging the COVID Gap (Year)

ByAngela Labrecque

When COVID-19 took over our lives in 2020, many felt the immediate need to help, but weren’t quite sure how. Carl May, grandson of company founder Dr. Harold W. Andersen, didn’t hesitate. He pressed pause on plans to attend college in Fall 2020 & joined Andersen’s contract sterilization sister company, Andersen Scientific, as a sterile processing technician where he spent months sterilizing millions of COVID test swabs for manufacturers across the country.

Andersen Partners with North Carolina Biotechnology Center to Advance Life Sciences Industry
| |

Andersen Partners with North Carolina Biotechnology Center to Advance Life Sciences Industry

ByAngela Labrecque

Andersen recently welcomed leadership from North Carolina Biotechnology Center (NCBiotech) to tour its manufacturing campus in Haw River, NC, and industrial sterilization sister company, Andersen Scientific in Morrisville, NC. Andersen works with NCBiotech to provide critical sterilization resources for start-ups, R&D departments and companies developing strategies to bring devices to market in North Carolina.

Andersen: FDA Innovation Challenge Winner
| | | |

Andersen: FDA Innovation Challenge Winner

ByAngela Labrecque

Andersen Sterilizers is pleased to announce its sister company, Andersen Scientific, has been selected by the Food and Drug Administration (FDA) as one of eight international companies it will collaborate with in the development of strategies or technologies to reduce ethylene oxide (EO) emissions to as close to zero as possible.